1. Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10+ advanced non-small cell lung cancer. Issue 1 (27th January 2022) Authors: Blumenschein, George R; Devarakonda, Siddhartha; Johnson, Melissa; Moreno, Victor; Gainor, Justin; Edelman, Martin J; Heymach, John V; Govindan, Ramaswamy; Bachier, Carlos; Doger de Spéville, Bernard; Frigault, Matthew J; Olszanski, Anthony J; Lam, Vincent K; Hyland, Natalie; Navenot, Jean-Marc; ... Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗